Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Siegel Jolie Create: Alert

All | News | Filings
Date FiledTypeDescription
02/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2022 4/A Siegel Jolie (Chief Legal Officer) has filed a Form 4 on C4 Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,102 shares @ $7.01, valued at $7.7k
05/27/2022 4 Siegel Jolie (Chief Legal Officer) has filed a Form 4 on C4 Therapeutics, Inc.
Txns: Exercised 3,750 options to buy @ $0
02/16/2022 4 Siegel Jolie (Chief Legal Officer) has filed a Form 4 on C4 Therapeutics, Inc.
Txns: Granted 90,000 options to buy @ $22.71, valued at $2M
Granted 26,250 options to buy @ $0
09/14/2021 4 Siegel Jolie (Chief Legal Officer) has filed a Form 4 on C4 Therapeutics, Inc.
Txns: Sold 12,500 shares @ $50, valued at $625k
Exercised 12,500 options to buy @ $4.98, valued at $62.3k
08/02/2021 4 Siegel Jolie (Chief Legal Officer) has filed a Form 4 on C4 Therapeutics, Inc.
Txns: Sold 12,500 shares @ $45, valued at $562.5k
Exercised 12,500 options to buy @ $4.98, valued at $62.3k
02/16/2021 4 Siegel Jolie (Chief Legal Officer) has filed a Form 4 on C4 Therapeutics, Inc.
Txns: Granted 84,850 options to buy @ $45.54, valued at $3.9M
05/06/2020 4 Siegel Jolie (VP, General Counsel) has filed a Form 4 on Neon Therapeutics, Inc.
Txns: Disposed/sold 161,821 shares @ $0
Disposed/sold 60,000 options to buy @ $6.13, valued at $367.8k
Disposed/sold 100,000 options to buy @ $12, valued at $1.2M
03/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/27/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/13/2020 4 Siegel Jolie (VP, General Counsel) has filed a Form 4 on Neon Therapeutics, Inc.
Txns: Granted 65,000 shares @ $0
11/25/2019 4 Siegel Jolie (VP, General Counsel) has filed a Form 4 on Neon Therapeutics, Inc.
Txns: Granted 75,000 shares @ $0
03/01/2019 4 Siegel Jolie (VP, General Counsel) has filed a Form 4 on Neon Therapeutics, Inc.
Txns: Granted 30,000 shares @ $0
Granted 60,000 options to buy @ $6.13, valued at $367.8k
03/01/2019 3 Siegel Jolie (VP, General Counsel) has filed a Form 3 on Neon Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy